1 false false false false false false false false false false true false false false false false false No description of principal activity 2025-02-01 Sage Accounts Production Advanced 2025 - FRS102_2025 4,197 2,525 2,241 4,481 2,706 1,494 2,054 2,146 2,335 1,491 xbrli:pure xbrli:shares iso4217:GBP 09386579 2025-02-01 2026-01-31 09386579 2026-01-31 09386579 2025-01-31 09386579 2024-02-01 2025-01-31 09386579 2025-01-31 09386579 2024-01-31 09386579 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 09386579 bus:Director1 2025-02-01 2026-01-31 09386579 core:WithinOneYear 2026-01-31 09386579 core:WithinOneYear 2025-01-31 09386579 core:ShareCapital 2026-01-31 09386579 core:ShareCapital 2025-01-31 09386579 core:RetainedEarningsAccumulatedLosses 2026-01-31 09386579 core:RetainedEarningsAccumulatedLosses 2025-01-31 09386579 core:BetweenOneFiveYears 2025-01-31 09386579 bus:Director1 2025-01-31 09386579 bus:Director1 2026-01-31 09386579 bus:Director1 2024-01-31 09386579 bus:Director1 2025-01-31 09386579 bus:Director1 2024-02-01 2025-01-31 09386579 bus:SmallEntities 2025-02-01 2026-01-31 09386579 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 09386579 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 09386579 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 09386579 bus:FullAccounts 2025-02-01 2026-01-31 09386579 bus:OrdinaryShareClass1 2026-01-31 09386579 bus:OrdinaryShareClass1 2025-01-31 09386579 core:FurnitureFittingsToolsEquipment 2025-01-31 09386579 core:FurnitureFittingsToolsEquipment 2025-02-01 2026-01-31 09386579 core:FurnitureFittingsToolsEquipment 2026-01-31
COMPANY REGISTRATION NUMBER: 09386579
The London Hip And Knee Clinic Ltd
Filleted Unaudited Financial Statements
For the year ended
31 January 2026
The London Hip And Knee Clinic Ltd
Financial Statements
Year ended 31 January 2026
Contents
Pages
Statement of financial position
1 to 2
Notes to the financial statements
3 to 6
The London Hip And Knee Clinic Ltd
Statement of Financial Position
31 January 2026
2026
2025
Note
£
£
£
Fixed assets
Tangible assets
5
2,335
1,491
Current assets
Debtors
6
511,103
333,867
Cash at bank and in hand
346,626
330,714
---------
---------
857,729
664,581
Creditors: amounts falling due within one year
7
138,315
121,761
---------
---------
Net current assets
719,414
542,820
---------
---------
Total assets less current liabilities
721,749
544,311
---------
---------
Net assets
721,749
544,311
---------
---------
Capital and reserves
Called up share capital
8
1
1
Profit and loss account
721,748
544,310
---------
---------
Shareholders funds
721,749
544,311
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
The London Hip And Knee Clinic Ltd
Statement of Financial Position (continued)
31 January 2026
These financial statements were approved by the board of directors and authorised for issue on 29 October 2026 , and are signed on behalf of the board by:
Mr Bhupinder S Mann
Director
Company registration number: 09386579
The London Hip And Knee Clinic Ltd
Notes to the Financial Statements
Year ended 31 January 2026
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Monington House, 20 Penington Road, Beaconsfield, England, HP9 1ET.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in UK sterling, which is the functional currency of the entity. Monetary amounts in these financial statements are rounded to the nearest UK pound.
Trade receivables
Trade receivable do not carry any interest and are stated at their original invoice value as reduced by appropriate allowances for estimated irrecoverable amounts.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax. Revenue from services provided is recognised when the significant risks and rewards have transferred to the buyer, usually on the provision of services.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income. In this case, tax is recognised in other comprehensive income. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
33.33% Straight line
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
5. Tangible assets
Equipment
Total
£
£
Cost
At 1 February 2025
4,197
4,197
Additions
2,525
2,525
Disposals
( 2,241)
( 2,241)
-------
-------
At 31 January 2026
4,481
4,481
-------
-------
Depreciation
At 1 February 2025
2,706
2,706
Charge for the year
1,494
1,494
Disposals
( 2,054)
( 2,054)
-------
-------
At 31 January 2026
2,146
2,146
-------
-------
Carrying amount
At 31 January 2026
2,335
2,335
-------
-------
At 31 January 2025
1,491
1,491
-------
-------
6. Debtors
2026
2025
£
£
Trade debtors
63,545
57,310
Other debtors
447,558
276,557
---------
---------
511,103
333,867
---------
---------
7. Creditors: amounts falling due within one year
2026
2025
£
£
Social security and other taxes
122,948
113,301
Other creditors
15,367
8,460
---------
---------
138,315
121,761
---------
---------
8. Called up share capital
Issued, called up and fully paid
2026
2025
No.
£
No.
£
Ordinary shares of £ 1 each
1
1
1
1
----
----
----
----
9. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
2026
2025
£
£
Not later than 1 year
9,571
14,357
Later than 1 year and not later than 5 years
–
9,571
-------
--------
9,571
23,928
-------
--------
10. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2026
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr Bhupinder S Mann
248,282
351,453
( 180,542)
419,193
---------
---------
---------
---------
2025
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mr Bhupinder S Mann
174,745
280,661
( 207,124)
248,282
---------
---------
---------
---------
An amount of £11,504 (2025 - £4,706) based on the official rate of interest on beneficial loan of 2.25% & 3.75% (2025 - 2.25%) was charged on the loan to the director.
11. Related party transactions
The company entered into the following related party transactions during the year:
Nature of Relationship Transaction Type 2026 2025
£ £
Director Balance due to/(from) (419,193) (248,282)
An amount of £11,504 (2025 - £4,706) based on the official rate of interest on beneficial loan of 2.25% & 3.75% (2025 - 2.25%) was charged on the loan to the director.